Trade Mark Litigation

Published: 1 March 2013

Due to the success of the first edition, published in 2008, Thierry Calame of Lenz & Staehelin and Massimo Sterpi of Jacobacci & Associati have agreed to lead the second edition of Trade Mark Litigation – jurisdictional comparisons.

This title:

  • Explains the latest legislation and precedents involving trade mark litigation in over 30 jurisdictions
  • Adopts a country-by-country approach, with content provided by expert practitioners from each of the jurisdictions, following a common format to allow straightforward comparisons
  • Takes into account the enormous expansion of digital commerce and the growing roles of trade mark registration in fighting abuses on the internet
  • Answers such questions as ‘can I oppose or cancel this trade mark?’ in a particular country, and the basis for taking such action – like national or supranational rights, and the procedures for doing so
  • Sets out each country’s courts and administrative system
  • Looks at the available enforcement options
  • Goes through civil court procedure
  • Indentifies the available remedies
  • Covers trade mark enforcement against metatag
  • Examines unjustified threats of trade mark infringement
  • Looks at conflicts between trade mark and domain name

Related publications

SEE ALL

Insights

Insights – 04.08.2026

Switzerland steps up: Federal Patent Court affirms cross-border reach in patent litigation

Switzerland steps up: Federal Patent Court affirms cross-border reach in…

<p><strong>Switzerland as a forum for cross-border patent enforcement: the Federal Patent Court confirms its reach</strong></p> <p class="MsoBodyText">In a landmark decision of 17 July 2026 (S2025_003), the Swiss Federal Patent Court has sent a clear signal: Switzerland is very much in the game when it comes to cross-border patent enforcement. The Court confirmed that claims for infringement of foreign patent designations can be heard at the defendant’s Swiss domicile and established a powerful principle of parallel infringement analysis across all EPC member states. For patent holders pursuing multi-jurisdictional strategies, Switzerland must be on the map.</p> <p class="MsoBodyText">The case arose from interim proceedings brought by Regeneron Pharmaceuticals, Inc., Bayer HealthCare LLC and Bayer Consumer Care AG against Sandoz Group AG, Sandoz AG and Sandoz Pharmaceuticals AG. The claimants sought a pan-European injunction against the distribution of Sandoz’ aflibercept biosimilar, relying on both the Swiss designation and multiple foreign designations of a European patent. The case thus presented the Court with a textbook scenario for testing Switzerland’s credentials as a cross-border patent litigation forum.</p> <p class="MsoBodyText">The Court rose to the occasion, delivering clear guidance on two issues that matter for any cross-border patent strategy:</p>

Insights – 03.11.2025

Draft bill on communication platforms and search engines in Switzerland

Draft bill on communication platforms and search engines in Switzerland

SEE ALL
Lenz & Staehelin {PAGENO}/{nbpg}
{PAGENO}/{nbpg}